Cenobamate in Real‐Word Scenario: Results on Efficacy, Side Effects, and Retention Rate in a Single Center Retrospective Study
ABSTRACT Background Pharmacoresistance imposes a high burden on people with epilepsy (PWE). Recently authorized cenobamate (CNB) offers new hope with high efficacy reported in phase III and early real‐world studies. Here, we present data from a reasonably sized monocentric cohort, complementing the...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Brain and Behavior |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brb3.70567 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|